CardioGenesis Corp., Chiron deal

The companies will develop methods to enhance transmyocardial revascularization (TMR) to treat

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE